[1]
2019. Synthesis of New inhibitors of the FibrillogenesisAß42: Alzheimer’s Disease. Medical Technologies Journal. 2, 4 (Jan. 2019), 315–315. DOI:https://doi.org/10.26415/2572-004X-vol2iss4p315-315.